108 related articles for article (PubMed ID: 10504869)
1. Management of pulmonary tuberculosis PTB: regimen employed in Lagos, Nigeria.
Alakpa GE; Edet EA
West Afr J Med; 1999; 18(2):119-23. PubMed ID: 10504869
[TBL] [Abstract][Full Text] [Related]
2. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
3. Pattern of some haematological indices in newly diagnosed pulmonary tuberculosis cases in Iwo, Nigeria: diagnostic and therapeutic implications.
Dosumu EA
Niger J Med; 2001; 10(1):18-20. PubMed ID: 11705048
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Bartacek A; Schütt D; Panosch B; Borek M;
Int J Tuberc Lung Dis; 2009 Jun; 13(6):760-6. PubMed ID: 19460254
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Kawakami K
Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
[TBL] [Abstract][Full Text] [Related]
7. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Dosumu EA
Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759
[TBL] [Abstract][Full Text] [Related]
8. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
Wada M
Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
10. Compliance in pulmonary tuberculosis patients using directly observed treatment short course.
Dosumu EA
Afr J Med Med Sci; 2001; 30(1-2):111-4. PubMed ID: 14510163
[TBL] [Abstract][Full Text] [Related]
11. [The study on the duration of treatment in the standard short course chemotherapy containing pyrazinamide].
Yamazaki Y; Matsumoto H; Fujiuchi S
Kekkaku; 2002 Jul; 77(7):513-9. PubMed ID: 12187815
[TBL] [Abstract][Full Text] [Related]
12. Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India?
Prasad R; Nautiyal RG; Mukherji PK; Jain A; Singh K; Ahuja RC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):895-902. PubMed ID: 12365576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
Ige OM; Sogaolu OM; Odaibo GN; Olaleye OD
Afr J Med Med Sci; 2004 Sep; 33(3):259-62. PubMed ID: 15819474
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
16. A survey of prescribing pattern for osteoarticular tuberculosis: orthopaedic surgeons' and infectious disease experts' perspective.
Agarwal A; Arora A; Kumar S
Indian J Tuberc; 2009 Oct; 56(4):201-5. PubMed ID: 20469731
[TBL] [Abstract][Full Text] [Related]
17. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
18. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
19. Treatment of tuberculosis.
Child Health Dialogue; 1996; Suppl():8-9. PubMed ID: 12292166
[TBL] [Abstract][Full Text] [Related]
20. Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
